卫光生物(002880) - 2020 Q1 - 季度财报

Revenue and Profitability - Revenue for Q1 2020 was CNY 189,466,467.56, an increase of 12.18% compared to CNY 168,889,078.86 in the same period last year[8] - Net profit attributable to shareholders was CNY 31,681,563.25, up 17.43% from CNY 26,979,739.00 year-on-year[8] - The company's operating income for the current period is 189,442,536.83 CNY, an increase of 12.5% compared to 168,889,078.86 CNY in the previous period[62] - The net profit for the current period is 31,460,821.75 CNY, representing a growth of 16.4% from 26,979,739.00 CNY in the previous period[61] - The total comprehensive income for the current period is 31,460,821.75 CNY, compared to 26,979,739.00 CNY in the previous period, indicating a growth of 16.4%[61] - The total profit for the current period is 37,621,222.65 CNY, up from 32,232,872.84 CNY in the previous period, showing an increase of 16.8%[61] Cash Flow and Liquidity - Net cash flow from operating activities reached CNY 59,296,567.78, a significant increase of 482.35% compared to a negative cash flow of CNY -15,508,316.50 in the previous year[8] - The company reported a cash flow from operating activities of 199,357,599.24 CNY, compared to 156,652,390.87 CNY in the previous period, reflecting a growth of 27.2%[70] - Total cash inflow from operating activities reached 201,914,503.07, compared to 156,872,653.45 in the prior period, indicating a growth of approximately 28.6%[74] - Cash outflow from operating activities decreased to 142,617,935.29 from 172,380,969.95, reflecting a reduction of about 17.3%[74] - The total cash and cash equivalents at the end of the period increased to 613,505,024.91 from 207,413,982.93, marking a rise of approximately 195.5%[76] - Cash and cash equivalents increased by 101.41% compared to the beginning of the year, mainly due to increased bank borrowings[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,852,357,209.14, reflecting a growth of 16.84% from CNY 1,585,396,225.48 at the end of the previous year[8] - Total current assets as of March 31, 2020, amounted to CNY 1,280,522,080.52, compared to CNY 1,008,153,845.93 as of December 31, 2019[35] - Total liabilities increased to CNY 372,139,025.38 as of March 31, 2020, from CNY 136,638,863.47 as of December 31, 2019[41] - The total assets of the company reached ¥1,840,037,042.14, an increase from ¥1,577,015,014.97 as of December 31, 2019, representing a growth of approximately 16.67%[45] - The company's current assets totaled ¥1,229,608,484.76, up from ¥960,911,806.39, indicating a significant increase of about 27.91%[45] - The total liabilities amounted to ¥360,139,796.40, compared to ¥128,917,616.02 in the previous period, reflecting a substantial rise of approximately 179.73%[51] Expenses - Research and development expenses decreased by 46.54% year-on-year, primarily due to the non-utilization of high-value materials compared to Q1 2019[21] - Operating expenses increased by 394.77% year-on-year, mainly due to increased donations in Q1[22] - Cash paid for purchasing goods and accepting services decreased by 38.77% year-on-year, mainly due to reduced expenses for raw material procurement in Q1[22] - Taxes paid increased by 30.96% year-on-year, primarily due to an increase in prepaid corporate income tax[22] - Cash distributed as dividends, profits, or interest payments increased by 309.28% year-on-year, mainly due to interest payments on bank loans[22] - Research and development expenses for the first quarter were ¥5,677,469.27, a decrease from ¥10,619,924.17, indicating a reduction of about 46.66%[54] Other Financial Metrics - The company's weighted average return on equity was 2.16%, slightly up from 2.05% in the previous year[8] - Basic and diluted earnings per share for the current period are both 0.2933 CNY, up from 0.2498 CNY in the previous period, reflecting a 17.4% increase[61] - The company's total equity increased to ¥1,479,897,245.74 from ¥1,448,097,398.95, reflecting a growth of about 2.20%[51] - The company recorded other income of 81,736.54 CNY, compared to 0 CNY in the previous period, showing a positive contribution to the overall income[61] - The company experienced a decrease in sales expenses, which are reported at 4,381,790.89 CNY, down from 5,874,147.43 CNY in the previous period, indicating a reduction of 25.4%[62] Financing Activities - Short-term borrowings increased by CNY 260 million, attributed to additional bank loans[21] - Cash inflow from financing activities totaled 260,000,000.00, with a net cash flow of 259,290,133.37 after outflows[76] - The cash flow from financing activities showed a significant recovery, with a net increase of 259,290,133.37 compared to a net outflow of -24,173,441.67 previously[76] Audit and Reliability - The company did not undergo an audit for the first quarter report, which may affect the reliability of the financial data presented[83]